Article info
PDFInflammatory bowel disease
Original article
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study
- Correspondence to Dr William J Sandborn, Division of Gastroenterology, University of California San Diego, 9500 Gilman Drive, La Jolla, California, USA; wsandborn{at}ucsd.edu
Citation
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study
Publication history
- Received November 22, 2016
- Revised August 16, 2017
- Accepted August 17, 2017
- First published October 5, 2017.
Online issue publication
December 05, 2018
Article Versions
- Previous version (5 December 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/